Application
CLSTN2 Antibody (Center) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the CLSTN2 antibody detected the CLSTN2 protein (arrow).Application
CLSTN2 Antibody (Center) western blot analysis in mouse stomach tissue lysates (35ug/lane).This demonstrates the CLSTN2 antibody detected the CLSTN2 protein (arrow).| Product Name | CLSTN2 (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CLSTN2; CS2; Calsyntenin-2; Alcadein-gamma |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CS2 |
|---|---|
| Alternative Names | CLSTN2 CS2 Calsyntenin-2 Alcadein-gamma |
| Molecular Weight(MW) | 107006 Da |
| Function | May modulate calcium-mediated postsynaptic signals (By similarity) |
| Tissue Specificity | Restricted to the brain. |
| Cellular Localization | Cell membrane; Single-pass type I membrane protein (Potential). Endoplasmic reticulum membrane. Golgi apparatus membrane. Note=Most prominent in the postsynaptic specializations of asymmetric (type I) synapses with both axodendritic and axospinous localization (By similarity) |
| Entrez Gene | 64084 |
|---|---|
| Nucleotide Accession | NP_071414.2 |
Application
CLSTN2 Antibody (Center) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the CLSTN2 antibody detected the CLSTN2 protein (arrow).
Application
CLSTN2 Antibody (Center) western blot analysis in mouse stomach tissue lysates (35ug/lane).This demonstrates the CLSTN2 antibody detected the CLSTN2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
